A recent study has shed light on the complexities of using nanoparticles for targeted drug delivery in precision medicine. These nanocarriers are intended to transport therapeutic agents directly to the sites where they are needed most.
The research specifically examines the uneven release of drugs from these nanoparticles, which could potentially undermine the effectiveness of targeted therapies.
As precision medicine continues to evolve, understanding the behavior of nanocarriers will be crucial for improving treatment outcomes.